Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
State Street EVP Kathryn M. Horgan Sells $1.12M of Stock
Kathryn M. Horgan, EVP, sold 6,437 shares of State Street Corp at $173.88 a share, worth $1.12M in total on Nov 11, 2026. Shares held after the trade: 96,734 (-6.2%).
Lifeway Foods reported record quarterly net sales of $67.8 million for Q3 2026, marking its 28th consecutive quarter of year-over-year growth. While sales grew 18.6%, net income fell to $0.3 million due to elevated input costs for milk, packaging, and transportation. The company expects gross margin expansion in 2027 driven by planned price increases and capacity investments at its Waukesha facility.
Term
Q3 2026
“Lifeway delivered another record breaking quarter with net sales of $67.8 million, extending our streak of topline growth to 28 consecutive quarters. The consistent, volume-led growth we are seeing for our authentic Lifeway Kefir and Lifeway Farmer Cheese is extraordinary, reflecting the deep trust we have established with our growing consumer base and the ongoing commitment of our retailer partners.”
Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods
“Profitability this quarter continued to reflect an elevated input cost environment, and while we expect the cost pressure to persist in the fourth quarter, our outlook for 2027 has not changed. We expect the planned price increases across our portfolio to take effect with distributors and retailers on a rolling basis through the end of the year and into the first quarter of 2027.”
Julie Smolyansky, President and Chief Executive Officer of Lifeway Foods
Adtran Holdings Chairman & CEO Thomas R. Stanton Buys $172K of Stock
Thomas R. Stanton, Chairman & CEO, bought 40,000 shares of Adtran Holdings, Inc. at $4.30 a share, worth $172K in total on Nov 9, 2026. Shares held after the trade: 1,450,890 (+2.8%).
Interlink Electronics reported a net loss of $0.32 million for the quarter ended September 30, 2026, compared to a $0.34 million loss in the prior year period. While revenue increased to $3.06 million from $2.96 million, the company faced higher costs of revenue and continued operating losses, resulting in a year-to-date net loss of $0.41 million.
Nuwellis reported Q3 2026 financial results with net sales of $2.2 million and a 24% improvement in operating loss to $2.1 million. The company highlighted significant gross margin expansion to 69.5% and an 88% year-to-date increase in Aquadex console unit sales, which builds the installed base for future recurring revenue.
Term
Q3 2026
“We have made meaningful progress in strengthening Nuwellis both commercially and financially. Year to date, console unit sales have nearly doubled, expanding our installed base and creating a larger opportunity to grow recurring circuit revenue. Although our third quarter faced a tough comparison against the prior-year period when we fulfilled a significant backorder, the underlying momentum in our business remains strong, as evidenced by the growth in our pediatric segment.”
Mike McCormick, Nuwellis President and Chief Executive
For the quarter ended September 30, 2026, VirTra reported net sales of $7.6 million, a significant increase from $5.3 million in the prior year period, resulting in a net income of $2.16 million. However, for the nine-month period, net sales decreased to $16.8 million compared to $19.5 million in 2025, reflecting fluctuations in contract timing.
Linde Debt Financing Update with Citigroup Global Markets Limited
Linde plc issued €1.3 billion in aggregate principal amount of senior notes, consisting of €650 million of 3.700% notes due 2029 and €650 million of 4.000% notes due 2033. The notes were issued under the company's €25 billion European debt issuance programme and are guaranteed by subsidiaries Linde GmbH and Linde Inc. Net proceeds of approximately €1,295 million will be used for general corporate purposes.
For the nine months ended September 30, 2026, Mannatech reported net sales of $76.4 million and a net income of $10.9 million, a significant recovery from a $3.9 million net loss in the prior year period. This improvement was primarily driven by a $10.5 million income tax benefit and reduced operating expenses, despite a decline in overall net sales.
VirTra reported Q3 2026 financial results featuring a 42% year-over-year revenue increase to $7.6 million and a return to profitability with net income of $2.2 million. The company highlighted strong bookings of $10.3 million and a total backlog of $27.6 million, supported by new contract awards from U.S. Customs and Border Protection and the U.S. Army.
Term
Q3 2026
“Our third quarter results reflect continued improvement across the business, highlighted by strong revenue growth, accelerating bookings, and improved profitability. We are particularly encouraged by the acceleration in customer orders, which, together with our improving revenue performance, provides tangible evidence that demand is translating into business results.”
John Givens, CEO
“We are also seeing encouraging developments in the government funding environment. Following nearly two years of limited grant activity, funding programs are reopening and customers are actively pursuing new opportunities.”
Applied Materials reported record fourth quarter and fiscal year 2026 results, with quarterly revenue surging 53% year-over-year to $10.41 billion. The company achieved record annual revenue of $34.45 billion and record non-GAAP EPS of $12.89, driven by strong AI-related demand for semiconductors. Management highlighted that the company is on track to grow its Semiconductor Systems business by more than 40% in calendar 2026.
Term
FY2026
“Applied Materials delivered record results in fiscal 2026, and we are on track to grow our Semiconductor Systems business more than 40 percent in our calendar 2026. AI continues to fuel strong incremental demand for semiconductors and Applied has built the most-enabling portfolio to advance the AI-computing roadmap, putting us in a great position for multi-year revenue and profit growth.”
Gary Dickerson, President and CEO
“With technology leadership in the most critical areas of the wafer fab equipment market, Applied Materials increased fiscal fourth quarter revenue by 53 percent year over year and non-GAAP earnings per share by 92 percent. We generated record quarterly free cash flow of $2.6 billion and distributed over $2.4 billion to shareholders, including the largest quarterly share buyback in more than eight years.”
Heartflow reported Q3 2026 revenue of $72.9 million, a 57% year-over-year increase driven by strong U.S. case volume for its FFRCT and Plaque Analysis products. The company significantly raised its full-year 2026 revenue guidance to a range of $262 million to $264 million, citing rapid CCTA market growth and improved production efficiency.
Term
Q3 2026
“Our third quarter was excellent, with revenue accelerating for the third consecutive quarter and U.S. revenue growing at its fastest pace in 11 quarters. Our core FFRCT business remains durable, our installed base continues to expand rapidly, and activations of Heartflow Plaque Analysis are ramping ahead of plan, with utilization broadening across a wider share of applicable CCTAs.”
John Farquhar, President and CEO of Heartflow
“Strong performance across our diagnostic platform, along with disciplined execution of our commercial, innovation and clinical initiatives, gives us the confidence to raise our 2026 guidance once again. With continued momentum and a scaling business, we believe we are well-positioned to extend our market leadership, and we have increased confidence in our path to profitability.”
Arrowhead Pharmaceuticals reported significant revenue from collaborations with Novartis ($89.0 million) and Madrigal ($25.0 million) in fiscal 2026, while total R&D expenses rose 22% to $739.1 million due to pipeline progression. A major one-time operating expense of $215.0 million was recorded for the acquisition of a Priority Review Voucher to accelerate the plozasiran sNDA.
MACOM Technology Solutions Holdings, Inc. identifies significant risks related to environmental compliance, data privacy (GDPR, CCPA, CPRA), and the evolving legal landscape of AI technologies. The company also highlights stock price volatility, noting a 44.2% cumulative decline in mid-2026, and warns of potential dilution from future capital-raising activities.
GeoVax Labs, Inc. reported a net loss of $13.8 million for the nine months ended September 30, 2026, compared to $17.0 million in the prior year period. The company is prioritizing its GEO-MVA vaccine candidate for poxviruses and its Gedeptin oncology program, though both require additional financing to initiate upcoming Phase 3 and Phase 2 trials, respectively.
Assurant EVP, Pres, Global Conn Living Nair Biju Sells $1.05M of Stock
Nair Biju, EVP, Pres, Global Conn Living, sold 3,272 shares of Assurant, Inc. at $319.84 a share, worth $1.05M in total on Nov 10, 2026. Shares held after the trade: 20,975 (-13.5%).
EWSB Bancorp reported a net loss of $113,655 for the third quarter of 2026, an improvement from a $3.34 million loss in the prior year period which was impacted by a large tax provision. The company strengthened its capital position during the quarter through a stock offering and the issuance of preferred shares, totaling approximately $774,829 in net proceeds.
Vireo Growth Inc. reported a significant revenue increase to $253.7 million for the quarter ended September 30, 2026, compared to $91.7 million in the prior year, driven by multiple acquisitions including Eaze, Hawthorne, and C21. Despite higher gross profits, the company recorded a net loss of $24.0 million for the quarter, impacted by substantial current income tax expenses and transaction-related costs.
Lifeway Foods reported a significant increase in net sales to $197.7 million for the nine months ended September 30, 2026, compared to $157.1 million in the prior year. However, net income decreased to $5.1 million from $11.3 million year-over-year, primarily driven by higher cost of goods sold and increased selling expenses, including a substantial rise in advertising costs.
Smith Micro Software reported Q3 2026 revenue of $5.0 million, a 16% sequential increase and a year-over-year improvement from $4.3 million. The company achieved a five-year high gross margin of 81.6% and significantly narrowed its GAAP net loss to $1.7 million compared to $5.2 million in the prior year's quarter.
Term
Q3 2026
“Our third quarter marked our third consecutive quarter of sequential revenue growth as we continued to build on the momentum established in the first half of the year. Revenue increased 16% sequentially and gross margin rose to 81.6%, a five-year high.”
William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro
“Our pipeline continues to grow and yield high-quality opportunities, and I am confident in our ability to translate this momentum into long-term growth.”
William W. Smith Jr., president, chief executive officer, and chairman of the board of Smith Micro
Andersen Group reported Q3 2026 revenue of $337.3 million, an 18.7% increase year-over-year, driven by broad-based growth across all service lines and geographic regions. The company reported GAAP net income of $68.0 million and introduced full-year 2027 revenue guidance of $1.275 billion to $1.325 billion.
Clean Energy Fuels Director Andrew J. Littlefair Sells $184K of Stock
Andrew J. Littlefair, Director, sold 100,000 shares of Clean Energy Fuels Corp. at $1.84 a share, worth $184K in total on Nov 10, 2026. Shares held after the trade: 1,882,832 (-5.0%).
Legacy Education Inc. reported total assets of $86.9 million as of September 30, 2026, compared to $78.5 million at the end of the prior fiscal year. The company's stockholders' equity increased to $54.0 million, driven by growth in retained earnings and additional paid-in capital.
Advanced Biomed Inc. reported a net loss of $989,054 for the quarter ended September 30, 2026, as it transitioned from biotechnology to AI and financial software activities. The company's cash position decreased to $213,995, and it recognized a significant provision for credit losses of $612,636 during the period.
Alnylam Pharmaceuticals Insider Amy W. Schulman Buys $300K of Stock
Amy W. Schulman bought 1,910 shares of Alnylam Pharmaceuticals, Inc. at $156.82 a share, worth $300K in total on Nov 9, 2026. Shares held after the trade: 25,959 (+7.9%).
Applied Optoelectronics CFO Stefan J. Murry Sells $195K of Stock
Stefan J. Murry, CFO, sold 4,000 shares of Applied Optoelectronics, Inc. at $48.83 a share, worth $195K in total on Nov 10, 2026. Shares held after the trade: 353,223 (-1.1%).
Pluri Inc. reported a significant increase in net loss to $15.39 million for the quarter ended September 30, 2026, primarily driven by a $10.9 million charge for acquired in-process research and development related to the Fishway Transaction. Despite the loss, revenues grew to $759,000 compared to $316,000 in the prior year, and the company successfully raised capital through share issuances and a SAFE agreement.
SOPHiA Genetics Executive Chairman Jurgi Camblong Sells $65.9K of Stock
Jurgi Camblong, Executive Chairman, sold 8,500 shares of SOPHiA Genetics SA at $7.76 a share, worth $65.9K in total on Nov 10, 2026. Shares held after the trade: 3,378,650 (-0.3%).
Avalanche Treasury Corporation reported a net loss of $16.8 million for the nine months ended September 30, 2026, despite a profitable third quarter with net income of $54.6 million driven by changes in the fair value of digital assets. The company's balance sheet shows significant holdings in AVAX and USDC, with total assets decreasing from $190.9 million at year-end 2025 to $151.9 million.
SOPHiA Genetics Insider Kathy L. Hibbs Sells $48.5K of Stock
Kathy L. Hibbs sold 6,250 shares of SOPHiA Genetics SA at $7.76 a share, worth $48.5K in total on Nov 10, 2026. Shares held after the trade: 90,742 (-6.4%).
Frontdoor, Inc. has appointed Mary Hopkins as Vice President, Controller and Chief Accounting Officer, effective December 14, 2026. Her compensation package includes an annual base salary of $415,000, a 50% target bonus, a $250,000 sign-on cash bonus, and a $250,000 sign-on equity grant in restricted stock units.